Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

Share Price Information for Iconic Labs (ICON)

Share Price is delayed by 15 minutes
Get Live Data
1.70    0.00 (0.00%)
Bid:
1.55
Ask:
1.85
Spread: 0.30 (19.355%)
Market Cap: £264.88k
ICON Live PriceLast checked at - London Stock Exchange

Intraday Iconic Labs Share Chart

Finance Update and Intention to replace facility

10 Sep 2020 11:46

RNS Number : 6441Y
Iconic Labs PLC
10 September 2020
 

 

 

 

Iconic Labs Plc ("Iconic Labs" or the "Company") announces intention for no further notices of drawdown and replacement of facility

 

 

Iconic Labs Plc (LSE:ICON) (the "Company"), a multidivisional new media and technology business, today announces that under the previously announced financing facility (the "Facility") with European High Growth Opportunities Fund ("EHGOF"), the Company has notified EHGOF that it does not intend to serve any further notices to draw down under the Facility as of immediate effect and will seek to replace the Facility. This will include reaching an agreement to effect the repayment or cancellation of all existing accrued convertible debt under the Facility.

 

With the Company now experiencing material growth in activity, partially due to the management services contract with JOE Media, the Company intends not to serve any further notices to draw down under the Facility going forward.

 

Instead, and consistent with the previously announced intention of the Company to move towards conventional financing, the Company intends to replace the variable conversion price financing structure of the Facility with organic funding from revenues together with conventional issuance of ordinary equity capital and non-convertible debt. The Company will aim to restructure its financing in the next quarter and will provide updates in due course.

 

John Quinlan, CEO of Iconic Labs, said: "With progress across the business including the management services contract over JOE Media, we now finally have an opportunity to explore more conventional financing options for the Company going forward". 

 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

**ENDS**

 

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

 

Damon Heath

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

Iconic Labs ir@iconiclabs.co.uk

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFIFSSESSELU
Date   Source Headline
30th Nov 202211:15 amRNSConversion of Securities
1st Nov 20224:50 pmRNSSubscription of convertible notes
22nd Sep 20225:59 pmRNSResults of Creditors and General Meetings
30th Aug 20226:19 pmRNSSettlement and CVA
23rd Aug 20224:57 pmRNSRetraction of claims
8th Jun 20226:05 pmRNSAdministration & proposed CVA update
8th Dec 20216:21 pmRNSResults of General Meeting
26th Nov 202110:05 amRNSAdjournment to the GM
19th Nov 202111:25 amRNSAdjournment to the GM - Replacement
18th Nov 20214:00 pmRNSAdjournment to the GM
15th Nov 20214:54 pmRNSAdjournment of General Meeting
7th Oct 202110:33 amRNSGeneral Meeting – Further adjournment
25th Aug 20212:44 pmRNSNOTICE OF APPROVAL OF ADMINISTRATORS' PROPOSALS
12th Aug 20211:22 pmRNSGM update and adjournment notice
13th Jul 20216:38 pmRNSGM update and adjournment notice
1st Jul 20214:48 pmRNSGM update and adjournment notice
16th Jun 20214:56 pmRNSAnnouncement of resignation of directorship
15th Jun 20214:27 pmRNSUpdate on General Meeting
7th Jun 20217:30 amRNSSuspension - Iconic Labs Plc
4th Jun 20216:39 pmRNSAppointment of Administrators
1st Jun 20219:05 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
26th May 20214:55 pmRNSDirectorate Change
24th May 20212:06 pmRNSSecond Price Monitoring Extn
24th May 20212:00 pmRNSPrice Monitoring Extension
24th May 202111:05 amRNSSecond Price Monitoring Extn
24th May 202111:00 amRNSPrice Monitoring Extension
24th May 20219:36 amRNSDirectorate Change
24th May 20219:05 amRNSSecond Price Monitoring Extn
24th May 20219:00 amRNSPrice Monitoring Extension
21st May 20217:00 amRNSNotice of GM
20th May 202111:05 amRNSSecond Price Monitoring Extn
20th May 202111:00 amRNSPrice Monitoring Extension
19th May 20214:00 pmRNSDirectorate Change
10th May 202111:05 amRNSSecond Price Monitoring Extn
10th May 202111:00 amRNSPrice Monitoring Extension
10th May 20219:05 amRNSSecond Price Monitoring Extn
10th May 20219:00 amRNSPrice Monitoring Extension
10th May 20218:12 amRNSLetter of Intent Signed : Sting Industries
4th May 20214:41 pmRNSSecond Price Monitoring Extn
4th May 20214:36 pmRNSPrice Monitoring Extension
4th May 20212:06 pmRNSSecond Price Monitoring Extn
4th May 20212:01 pmRNSPrice Monitoring Extension
30th Apr 20214:41 pmRNSSecond Price Monitoring Extn
30th Apr 20214:35 pmRNSPrice Monitoring Extension
30th Apr 20212:17 pmRNSHalf-year Report
29th Apr 20217:52 amRNSDirectorate Change
23rd Apr 202111:05 amRNSSecond Price Monitoring Extn
23rd Apr 202111:00 amRNSPrice Monitoring Extension
21st Apr 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.